A Prospective Randomized Comparison of an Attached Silver-Impregnated Cuff to Prevent Central Venous Catheter-Associated Infection

Harriet O. Smith, Carol L. DeVictoria, David Garfinkel, Patrick Anderson, Gary L. Goldberg, Robert Soeiro, G. Elia, Carolyn D. Runowicz

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The VitaCuff catheter, a specialized central venous catheter (CVC) with an attached silver-impregnated cuff, is designed to permit percutaneous placement and prolonged venous access. A prospective randomized study was undertaken comparing the VitaCuff with standard triple lumen catheters to determine if the VitaCuff reduces infection during extended use. All consenting patients underwent percutaneous placement of subclavian lines. By study design, control and VitaCuff catheters could remain in site for up to 7 and 14 days, respectively. Cultures were obtained from the preinsertion skin site, and upon removal, from the skin, hubs, infusates, CVC tip, and cuff. Statistical methods included χ2, the Student t test, and the log-rank test on Kaplan-Meier estimates. Of 133 patients completing this study, 64 patients (48.1%) underwent VitaCuff placement and 69 patients (51.8%) served as controls. In 124 patients (93.2%), the indication for catheter placement was for perioperative care. Overall, 67 patients (50.4%) required central venous access >7 days. necessitating ≥1 additional line in 29 patients (21.8%). The incidence of pneumothorax per patient from the initial central line insertion was 4/104 (3.85%), significantly lower than the 4/29 (13.8%) incidence during secondary catheter placement (P = 0.046). Culture results upon catheter removal demonstrated a reduction in colonization of skin sites and hubs for the VitaCuff patients, but not for catheter tips or infusates. Regardless of the type of catheter used, colonization was dependent upon duration of insertion. The incidence of catheter-related sepsis was 6.8%, and did not differ significantly between the study groups. Multiple CVC insertions increase the incidence of pneumothorax. Because VitaCuff catheters permit extended access up to 14 days without increasing the incidence of sepsis, we recommend their use in patients who require prolonged CVC access.

Original languageEnglish (US)
Pages (from-to)92-100
Number of pages9
JournalGynecologic Oncology
Volume58
Issue number1
DOIs
StatePublished - Jul 1995

Fingerprint

Catheter-Related Infections
Central Venous Catheters
Silver
Catheters
Incidence
Pneumothorax
Skin
Sepsis
Perioperative Care
Kaplan-Meier Estimate
Prospective Studies
Students

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

A Prospective Randomized Comparison of an Attached Silver-Impregnated Cuff to Prevent Central Venous Catheter-Associated Infection. / Smith, Harriet O.; DeVictoria, Carol L.; Garfinkel, David; Anderson, Patrick; Goldberg, Gary L.; Soeiro, Robert; Elia, G.; Runowicz, Carolyn D.

In: Gynecologic Oncology, Vol. 58, No. 1, 07.1995, p. 92-100.

Research output: Contribution to journalArticle

Smith, HO, DeVictoria, CL, Garfinkel, D, Anderson, P, Goldberg, GL, Soeiro, R, Elia, G & Runowicz, CD 1995, 'A Prospective Randomized Comparison of an Attached Silver-Impregnated Cuff to Prevent Central Venous Catheter-Associated Infection', Gynecologic Oncology, vol. 58, no. 1, pp. 92-100. https://doi.org/10.1006/gyno.1995.1189
Smith, Harriet O. ; DeVictoria, Carol L. ; Garfinkel, David ; Anderson, Patrick ; Goldberg, Gary L. ; Soeiro, Robert ; Elia, G. ; Runowicz, Carolyn D. / A Prospective Randomized Comparison of an Attached Silver-Impregnated Cuff to Prevent Central Venous Catheter-Associated Infection. In: Gynecologic Oncology. 1995 ; Vol. 58, No. 1. pp. 92-100.
@article{74197516e3d6446cad1a514a22ad35ee,
title = "A Prospective Randomized Comparison of an Attached Silver-Impregnated Cuff to Prevent Central Venous Catheter-Associated Infection",
abstract = "The VitaCuff catheter, a specialized central venous catheter (CVC) with an attached silver-impregnated cuff, is designed to permit percutaneous placement and prolonged venous access. A prospective randomized study was undertaken comparing the VitaCuff with standard triple lumen catheters to determine if the VitaCuff reduces infection during extended use. All consenting patients underwent percutaneous placement of subclavian lines. By study design, control and VitaCuff catheters could remain in site for up to 7 and 14 days, respectively. Cultures were obtained from the preinsertion skin site, and upon removal, from the skin, hubs, infusates, CVC tip, and cuff. Statistical methods included χ2, the Student t test, and the log-rank test on Kaplan-Meier estimates. Of 133 patients completing this study, 64 patients (48.1{\%}) underwent VitaCuff placement and 69 patients (51.8{\%}) served as controls. In 124 patients (93.2{\%}), the indication for catheter placement was for perioperative care. Overall, 67 patients (50.4{\%}) required central venous access >7 days. necessitating ≥1 additional line in 29 patients (21.8{\%}). The incidence of pneumothorax per patient from the initial central line insertion was 4/104 (3.85{\%}), significantly lower than the 4/29 (13.8{\%}) incidence during secondary catheter placement (P = 0.046). Culture results upon catheter removal demonstrated a reduction in colonization of skin sites and hubs for the VitaCuff patients, but not for catheter tips or infusates. Regardless of the type of catheter used, colonization was dependent upon duration of insertion. The incidence of catheter-related sepsis was 6.8{\%}, and did not differ significantly between the study groups. Multiple CVC insertions increase the incidence of pneumothorax. Because VitaCuff catheters permit extended access up to 14 days without increasing the incidence of sepsis, we recommend their use in patients who require prolonged CVC access.",
author = "Smith, {Harriet O.} and DeVictoria, {Carol L.} and David Garfinkel and Patrick Anderson and Goldberg, {Gary L.} and Robert Soeiro and G. Elia and Runowicz, {Carolyn D.}",
year = "1995",
month = "7",
doi = "10.1006/gyno.1995.1189",
language = "English (US)",
volume = "58",
pages = "92--100",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - A Prospective Randomized Comparison of an Attached Silver-Impregnated Cuff to Prevent Central Venous Catheter-Associated Infection

AU - Smith, Harriet O.

AU - DeVictoria, Carol L.

AU - Garfinkel, David

AU - Anderson, Patrick

AU - Goldberg, Gary L.

AU - Soeiro, Robert

AU - Elia, G.

AU - Runowicz, Carolyn D.

PY - 1995/7

Y1 - 1995/7

N2 - The VitaCuff catheter, a specialized central venous catheter (CVC) with an attached silver-impregnated cuff, is designed to permit percutaneous placement and prolonged venous access. A prospective randomized study was undertaken comparing the VitaCuff with standard triple lumen catheters to determine if the VitaCuff reduces infection during extended use. All consenting patients underwent percutaneous placement of subclavian lines. By study design, control and VitaCuff catheters could remain in site for up to 7 and 14 days, respectively. Cultures were obtained from the preinsertion skin site, and upon removal, from the skin, hubs, infusates, CVC tip, and cuff. Statistical methods included χ2, the Student t test, and the log-rank test on Kaplan-Meier estimates. Of 133 patients completing this study, 64 patients (48.1%) underwent VitaCuff placement and 69 patients (51.8%) served as controls. In 124 patients (93.2%), the indication for catheter placement was for perioperative care. Overall, 67 patients (50.4%) required central venous access >7 days. necessitating ≥1 additional line in 29 patients (21.8%). The incidence of pneumothorax per patient from the initial central line insertion was 4/104 (3.85%), significantly lower than the 4/29 (13.8%) incidence during secondary catheter placement (P = 0.046). Culture results upon catheter removal demonstrated a reduction in colonization of skin sites and hubs for the VitaCuff patients, but not for catheter tips or infusates. Regardless of the type of catheter used, colonization was dependent upon duration of insertion. The incidence of catheter-related sepsis was 6.8%, and did not differ significantly between the study groups. Multiple CVC insertions increase the incidence of pneumothorax. Because VitaCuff catheters permit extended access up to 14 days without increasing the incidence of sepsis, we recommend their use in patients who require prolonged CVC access.

AB - The VitaCuff catheter, a specialized central venous catheter (CVC) with an attached silver-impregnated cuff, is designed to permit percutaneous placement and prolonged venous access. A prospective randomized study was undertaken comparing the VitaCuff with standard triple lumen catheters to determine if the VitaCuff reduces infection during extended use. All consenting patients underwent percutaneous placement of subclavian lines. By study design, control and VitaCuff catheters could remain in site for up to 7 and 14 days, respectively. Cultures were obtained from the preinsertion skin site, and upon removal, from the skin, hubs, infusates, CVC tip, and cuff. Statistical methods included χ2, the Student t test, and the log-rank test on Kaplan-Meier estimates. Of 133 patients completing this study, 64 patients (48.1%) underwent VitaCuff placement and 69 patients (51.8%) served as controls. In 124 patients (93.2%), the indication for catheter placement was for perioperative care. Overall, 67 patients (50.4%) required central venous access >7 days. necessitating ≥1 additional line in 29 patients (21.8%). The incidence of pneumothorax per patient from the initial central line insertion was 4/104 (3.85%), significantly lower than the 4/29 (13.8%) incidence during secondary catheter placement (P = 0.046). Culture results upon catheter removal demonstrated a reduction in colonization of skin sites and hubs for the VitaCuff patients, but not for catheter tips or infusates. Regardless of the type of catheter used, colonization was dependent upon duration of insertion. The incidence of catheter-related sepsis was 6.8%, and did not differ significantly between the study groups. Multiple CVC insertions increase the incidence of pneumothorax. Because VitaCuff catheters permit extended access up to 14 days without increasing the incidence of sepsis, we recommend their use in patients who require prolonged CVC access.

UR - http://www.scopus.com/inward/record.url?scp=0029022799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029022799&partnerID=8YFLogxK

U2 - 10.1006/gyno.1995.1189

DO - 10.1006/gyno.1995.1189

M3 - Article

C2 - 7789897

AN - SCOPUS:0029022799

VL - 58

SP - 92

EP - 100

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -